Kyoto Breast Cancer Consensus Conference 2021 International Convention

講演情報

印刷

Sponsored Symposium

Lecture

[11] Sponsored Symposium-2

Co-organized with Novartis Pharma K.K.

2021年2月6日(土) 07:30 〜 08:00 ROOM1 (Japan Standard Time)

07:00 〜 08:00

[2L01] Optimal sequential endocrine treatment with targeted therapies in postmenopausal ER-positive/HER2-negative advanced breast cancer

*Yutaka Yamamoto1 (1. Department of Breast and Endocrine Surgery, Graduate School of Medical Sciences, Kumamoto University)

Abstract password authentication.
This password was already sent to your registered e-mail address from secretariat.

パスワード